Novel 2-(azetidin-2-on-1-yl)alkanedioic acid derivatives and 2-(azetidin-2-on-1-yl)alkoxyalkanoic acid derivatives are described for use in the treatment of disease states responsive to antagonism of the vasopressin V.sub.1a receptor.

 
Web www.patentalert.com

< Multipolar pacing method and apparatus

< Bifurcated graft with a superior extension

> Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin

> Method of orally treating inflammatory skin conditions with prodrugs of 5-fluorouracil
~ 00294